Caverject Impulse Injection, Powder, Lyophilized, For Solution
Product Images NDC 0009-5182

29 FDA label images from Pharmacia & Upjohn Company Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Caverject Impulse (NDC 0009-5182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Injection Site (Caverject 01)

Injection Site (Caverject 01)
Chemical structure of Alprostadil, the active ingredient in Caverject Impulse injection powder, lyophilized for solution.*
FDA Label Image

Top Side (Caverject 02)

FDA Label Image

Chemical Structure (Caverject 03)

Chemical Structure (Caverject 03)
Illustration of the Caverject Impulse injection system components, showing a needle assembly with outer and inner protective caps, and superfine needle, along with the syringe containing a clear plastic tip with a glass cartridge inside, a dose window, and a plunger rod. The diagram identifies each part of the assembly clearly.*
FDA Label Image

Logo (Caverject 04)

FDA Label Image

Logo (Caverject 05)

Logo (Caverject 05)
An instructional illustration labeled 'Figure B' showing two hands assembling or preparing a pen-like injection device. One hand holds the device steady while the other hand aligns or attaches a small component at the top, demonstrating proper device preparation technique.*
FDA Label Image

Figure A (Caverject 06)

Figure A (Caverject 06)
Figure C is a black-and-white line drawing showing two hands preparing a vial, with one hand holding a vial and the other hand pulling off the vial cap. An arrow indicates the direction of cap removal. This instructional diagram likely relates to preparing the Caverject Impulse injection.*
FDA Label Image

Exclaim Image (Caverject 07)

Exclaim Image (Caverject 07)
Illustration labeled Figure D showing hands manipulating a vial and a syringe, demonstrating a step in preparing an injection, likely related to Caverject Impulse (Alprostadil) lyophilized powder for solution.*
FDA Label Image

Figure B (Caverject 08)

Figure B (Caverject 08)
An instructional illustration labeled Figure E showing a hand holding and operating a syringe device, likely demonstrating a step in preparation or administration of an injection. The syringe appears to have measurement markings and a plunger at the bottom.*
FDA Label Image

Figure C (Caverject 09)

Figure C (Caverject 09)
An instructional illustration labeled 'Fig. F' showing a hand holding and preparing a syringe for injection, likely demonstrating how to use the Caverject Impulse injection device for intracavernous administration.*
FDA Label Image

Figure D (Caverject 10)

Figure D (Caverject 10)
An instructional illustration showing a person holding a syringe and removing the cap from the needle, labeled as Figure G. This image relates to the preparation or use of an injection product.*
FDA Label Image

Figure E (Caverject 11)

Figure E (Caverject 11)
An instructional illustration showing a hand holding a syringe with a needle, demonstrating preparation or administration technique presumably related to Caverject Impulse injection.*
FDA Label Image

Figure F (Caverject 12)

Figure F (Caverject 12)
An instructional illustration labeled 'Figure I' showing a pair of hands preparing an injection device by removing a cap or protective cover from the needle. The image demonstrates part of the preparation process for administering an injection.*
FDA Label Image

Exclaim Image (Caverject 13)

Exclaim Image (Caverject 13)
An instructional diagram labeled Figure J, depicting a close-up view of a component with a numbered part labeled '5', likely part of the Caverject Impulse injection device for intracavernous administration of Alprostadil.*
FDA Label Image

Exclaim Image (Caverject 14)

Exclaim Image (Caverject 14)
Illustration labeled as Figure K showing injection sites for Caverject Impulse (alprostadil) intracavernous injection. Shaded areas on the diagram indicate the recommended locations for injection on a penile cross-section.*
FDA Label Image

Figure G (Caverject 15)

Figure G (Caverject 15)
Instructional diagram labeled Figure L showing an overhead cross-section of the corpora cavernosa with highlighted areas to avoid during injection. It includes labels for the top side, underside, and the angle (90°) indicating proper injection technique for intracavernous administration.*
FDA Label Image

Figure H (Caverject 16)

Figure H (Caverject 16)
Illustration showing hands administering an intracavernous injection. One hand holds a syringe with a needle, while the other hand is positioned to stabilize the injection site. The figure is labeled 'Figure M.'*
FDA Label Image

Exclaim Image (Caverject 17)

Exclaim Image (Caverject 17)
Label for Caverject Impulse 10 micrograms injection, a dual chamber system containing alprostadil for intracavernous use. The label indicates it is manufactured by Pharmacia & Upjohn Company LLC, a division of Pfizer Inc., made in Belgium, and includes a lot/expiration date area. The label warns to keep out of reach of children.*
FDA Label Image

Exclaim Image (Caverject 18)

Exclaim Image (Caverject 18)
Packaging label for Caverject Impulse 10 micrograms powder for injection, lyophilized for solution by Pfizer. The label indicates alprostadil for injection, intended for intracavernosal use only with a dual chamber system. The package contains 2 single dose injection systems and diluent that contains benzyl alcohol. It includes the NDC 0009-5181-01 and states Rx only.*
FDA Label Image

Figure I (Caverject 19)

Figure I (Caverject 19)
Label for Caverject Impulse 20 micrograms dual chamber system injection powder, lyophilized for solution. Contains alprostadil for injection, manufactured by Pharmacia & Upjohn Co, a division of Pfizer Inc, made in Belgium. Label includes barcode and space for lot and expiration date.*
FDA Label Image

Figure J (Caverject 21)

Figure J (Caverject 21)
An illustration labeled Figure J showing a close-up view of a device component marked with the number 5. The image likely relates to an assembly or usage step for Caverject Impulse injection but contains no textual instructions or dose information.*
FDA Label Image

Exclaim Image (Caverject 20)

Exclaim Image (Caverject 20)
Packaging label for Caverject Impulse 20 micrograms injection, a lyophilized powder for solution containing alprostadil for intracavernous use. The label shows the Pfizer logo and states the product contains 2 single dose injection systems with a diluent containing benzyl alcohol. It includes NDC 0009-5182-01 and notes the product is Rx only, distributed by Pharmacia & Upjohn Co., Division of Pfizer Inc.*
FDA Label Image

Figure K (Caverject 22)

Figure K (Caverject 22)
An instructional anatomical diagram labeled Figure K showing injection sites for Caverject Impulse (Alprostadil). The shaded areas on the sides of the penile shaft indicate recommended intracavernous injection locations.*
FDA Label Image

Figure L (Caverject 23)

Figure L (Caverject 23)
An instructional anatomical diagram showing a cross-section of the corpora cavernosa with guidance on injection technique. It highlights areas to avoid when injecting and illustrates injecting at a 90-degree angle on the top side of the corpora cavernosa.*
FDA Label Image

Figure M (Caverject 24)

Figure M (Caverject 24)
An instructional illustration labeled Figure M showing a hand holding an injection device and another hand positioned to receive an intracavernous injection, indicating the administration method for Caverject Impulse (Alprostadil) injection.*
FDA Label Image

Logo.jpg (Caverject 25)

FDA Label Image

Principal Display Panel (10 microgram Syringe Label)

Principal Display Panel (10 microgram Syringe Label)
Label for Caverject Impulse 10 micrograms dual chamber system injection containing alprostadil. The label notes it is for injection and distributed by Pharmacia & Upjohn Company LLC, a Pfizer subsidiary. Includes a barcode and space for lot and expiration information.*
FDA Label Image

Principal Display Panel (10 micrograms Syringe Carton)

Principal Display Panel (10 micrograms Syringe Carton)
Packaging label for Caverject Impulse 10 micrograms injection, a lyophilized powder for intracavernous use containing alprostadil. The label shows the Pfizer logo and states the product includes 2 single dose injection systems with a diluent containing benzyl alcohol. It is for prescription use only and distributed by Pharmacia & Upjohn Company LLC.*
FDA Label Image

Principal Display Panel (20 microgram Syringe Label)

Principal Display Panel (20 microgram Syringe Label)
Label for Caverject Impulse 20 micrograms injection, a dual chamber system containing alprostadil for intracavernous use. The label includes distributor information for Pharmacia & Upjohn Company LLC, a Pfizer subsidiary, and space for lot and expiration data.*
FDA Label Image

Principal Display Panel (20 micrograms Syringe Carton)

Principal Display Panel (20 micrograms Syringe Carton)
Packaging label for Caverject Impulse 20 micrograms injection (alprostadil) by Pfizer. The label indicates the product is for intracavernosal use only, supplied as injection powder with diluent containing benzyl alcohol, and contains 2 single dose injection systems. The label also includes NDC 0009-5182-01 and the Pfizer logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.